The authors assessed the efficacy of fluvoxamine versus placebo in preventing hospitalisation defined as either retention in a COVID-19 emergency setting or transfer to a tertiary hospital due to COVID-19.
[Lancet Global Health]
Sorry, but the selected Zotpress account can't be found.